PIAS2-2 SUMOylates THRA with SUMO1

Stable Identifier
R-HSA-4719447
Type
Reaction [transition]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
PIAS2-2 (PIASx-alpha) SUMOylates THRA (alpha-1 isoform) with SUMO1 at lysine-283 and lysine-389 (Liu et al. 2012). (A lysine residue corresponding to lysine-389 does not exist in the alpha-2 isoform.) SUMOylation by SUMO3 but not SUMO1 enhances induction of gene expression in response to the ligand triiodothyroxine.
Literature References
PubMed ID Title Journal Year
22930759 Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation

Schultz, JJ, Liu, YY, Kogai, T, Mody, K, Brent, GA

J. Biol. Chem. 2012
Participants
Participates
Catalyst Activity

SUMO transferase activity of PIAS2-2 [nucleoplasm]

Orthologous Events
Authored
Reviewed
Created
Cite Us!